Search - tctmd.com

Displaying 61 - 80 of 83

Sort: Relevancy | Date

Presentation TCT 2014

Case Presentation

Presenter: Sahil A. Parikh

September 17, 2014

Presentation TCT 2014

Master Class in SFA Technologies: Lining up the Data

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, William A. Gray

September 13, 2014

Presentation

Two-Year Results Following Treatment with the Stellarex DCB: ILLUMENATE FIH Study

Presenter: S. Duda

May 29, 2014

Presentation

Randomized Trial of IN.PACT Admiral DCB vs PTA for Atherosclerotic Lesions in the SFA and/or PPA

Presenter: Gunnar Tepe

April 14, 2014

Presentation

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of SFA de novo Lesions

Presenter: Martin Werner

February 19, 2014

Presentation

ESPRIT: Bioresorbable Scaffold in Peripheral Lesions

Presenter: Johannes Lammer

January 21, 2014

Presentation TCT 2013

SFA and Tibioperoneal Alternatives: Tailoring Therapeutic Choices

Presenter: Thomas Zeller

October 30, 2013

Presentation TCT 2013

Stenting Is the First-line Treatment for SFA Disease!

Presenter: J. Michael Bacharach

October 27, 2013

Presentation

Comparison of Surgical Bypass with Angioplasty and Stenting of SFA Disease

Presenter: MB Malas

August 12, 2013

Presentation

Heparin-bonded Covered Stents vs. BMS for Complex Femoro-popliteal Artery Lesions

Presenter: Johannes Lammer

July 16, 2013

Presentation TCT 2012

SFA Intervention: State of the Art Today and in 2020

Presenter: Gary Ansel

October 24, 2012

Presentation TCT 2012

What is the Potential Economic Impact of Antiproliferative Technologies in the SFA?

Presenter: Mark Burket

October 22, 2012

Presentation TCT 2012

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Presenter: Eugenio Stabile

October 22, 2012

Presentation TCT 2012

Development of a Bioabsorbable Scaffold for the SFA

Presenter: Richard Rapoza

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Presenter: Gary Ansel

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con!

Presenter: Lawrence Garcia

October 22, 2012

Presentation TCT 2012

Adventitial Injection for SFA Restenosis: Results of an Exploratory Study

Presenter: Christopher Owens

October 22, 2012

Presentation

COBRA: Pilot Trial of Cryoplasty or Conventional Balloon Post-Dilation of Nitinol Stents for PAD

Presenter: 17338|Subhash Banerjee

September 12, 2012

Presentation TCTAP 2012

What’s the Benchmark: Is there a Gold Standard for SFA Revascularization?

Presenter: Lawrence A. Garcia

April 25, 2012

Presentation

Clinical Evaluation of a Paclitaxel-Eluting Balloon for Treatment of Femoropopliteal Arterial Disease

Presenter: Antonio Micari

March 22, 2012

Advertisement

Case Presentation

Master Class in SFA Technologies: Lining up the Data

Two-Year Results Following Treatment with the Stellarex DCB: ILLUMENATE FIH Study

Randomized Trial of IN.PACT Admiral DCB vs PTA for Atherosclerotic Lesions in the SFA and/or PPA

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of SFA de novo Lesions

ESPRIT: Bioresorbable Scaffold in Peripheral Lesions

SFA and Tibioperoneal Alternatives: Tailoring Therapeutic Choices

Stenting Is the First-line Treatment for SFA Disease!

Comparison of Surgical Bypass with Angioplasty and Stenting of SFA Disease

Heparin-bonded Covered Stents vs. BMS for Complex Femoro-popliteal Artery Lesions

SFA Intervention: State of the Art Today and in 2020

What is the Potential Economic Impact of Antiproliferative Technologies in the SFA?

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Development of a Bioabsorbable Scaffold for the SFA

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con!

Adventitial Injection for SFA Restenosis: Results of an Exploratory Study

COBRA: Pilot Trial of Cryoplasty or Conventional Balloon Post-Dilation of Nitinol Stents for PAD

What’s the Benchmark: Is there a Gold Standard for SFA Revascularization?

Clinical Evaluation of a Paclitaxel-Eluting Balloon for Treatment of Femoropopliteal Arterial Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content